LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹9,336 Cr | ₹8,387 Cr | ₹7,660 Cr | ₹6,968 Cr | ₹5,751 Cr |
What is the latest Total Liabilities ratio of LAURUS LABS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹9,336 Cr |
Mar2024 | ₹8,387 Cr |
Mar2023 | ₹7,660 Cr |
Mar2022 | ₹6,968 Cr |
Mar2021 | ₹5,751 Cr |
How is Total Liabilities of LAURUS LABS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹9,336 Cr | 11.31 | |
Mar2024 | ₹8,387 Cr | 9.49 | |
Mar2023 | ₹7,660 Cr | 9.94 | |
Mar2022 | ₹6,968 Cr | 21.17 | |
Mar2021 | ₹5,751 Cr | - |
Compare Total Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹44,323.0 Cr | -4.7% | 3.5% | 94.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,702.0 Cr | -3.3% | -4.6% | -7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹156,908.0 Cr | -9% | -13.6% | 24% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,896.0 Cr | -1.1% | 7% | 8.2% | Stock Analytics | |
CIPLA | ₹119,988.0 Cr | -2% | 0.6% | -4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,122.0 Cr | -1.1% | -3.8% | -13.3% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | -4.7% |
3.5% |
94.1% |
SENSEX | -0.9% |
-4.4% |
1.6% |
You may also like the below Video Courses